- Home
- UCAR vs CARM Comparison
UCAR vs CARM Comparison
Compare UCAR & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCAR
- CARM
- Stock Information
- Founded
- UCAR 2013
- CARM 2016
- Country
- UCAR China
- CARM United States
- Employees
- UCAR N/A
- CARM N/A
- Industry
- UCAR Retail-Auto Dealers and Gas Stations
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- UCAR Consumer Discretionary
- CARM Health Care
- Exchange
- UCAR Nasdaq
- CARM Nasdaq
- Market Cap
- UCAR 10.1M
- CARM 12.1M
- IPO Year
- UCAR 2023
- CARM N/A
- Fundamental
- Price
- UCAR N/A
- CARM $0.16
- Analyst Decision
- UCAR Strong Buy
- CARM Hold
- Analyst Count
- UCAR 1
- CARM 5
- Target Price
- UCAR $5.00
- CARM $0.90
- AVG Volume (30 Days)
- UCAR 129.2K
- CARM 2.1M
- Earning Date
- UCAR 05-15-2026
- CARM 11-06-2025
- Dividend Yield
- UCAR N/A
- CARM N/A
- EPS Growth
- UCAR N/A
- CARM N/A
- EPS
- UCAR N/A
- CARM N/A
- Revenue
- UCAR $6,816,075.00
- CARM $10,767,000.00
- Revenue This Year
- UCAR N/A
- CARM N/A
- Revenue Next Year
- UCAR N/A
- CARM N/A
- P/E Ratio
- UCAR N/A
- CARM N/A
- Revenue Growth
- UCAR 57.22
- CARM N/A
- 52 Week Low
- UCAR $1.74
- CARM $0.14
- 52 Week High
- UCAR $9.43
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- UCAR 41.04
- CARM 29.49
- Support Level
- UCAR $1.93
- CARM $0.24
- Resistance Level
- UCAR $2.12
- CARM $0.29
- Average True Range (ATR)
- UCAR 0.10
- CARM 0.03
- MACD
- UCAR 0.01
- CARM -0.01
- Stochastic Oscillator
- UCAR 36.04
- CARM 5.24
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.